We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

95 hedge funds and large institutions have $473M invested in AVANIR PHARMACEUTICALS, INC CL A in 2013 Q2 according to their latest regulatory filings, with 95 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $5.99M | Put options by funds: $3.33M

Holders
95
Holders Change
+95
Holders Change %
% of All Funds
3.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
95
Increased
Reduced
Closed
Calls
$5.99M
Puts
$3.33M
Net Calls
+$2.67M
Net Calls Change
+$2.67M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
VOYA Investment Management
51
VOYA Investment Management
Georgia
$443K +$331K +96,224 New
AIG
52
American International Group
New York
$432K +$323K +94,002 New
BA
53
BlackRock Advisors
Delaware
$407K +$304K +88,429 New
Citadel Advisors
54
Citadel Advisors
Florida
$396K +$296K +85,980 New
Morgan Stanley
55
Morgan Stanley
New York
$354K +$265K +77,116 New
Group One Trading
56
Group One Trading
Illinois
$327K +$245K +71,190 New
CL
57
Croft-Leominster
Maryland
$323K +$241K +70,200 New
Commonwealth Equity Services
58
Commonwealth Equity Services
Massachusetts
$312K +$233K +67,843 New
FAM
59
Fortaleza Asset Management
Illinois
$284K +$212K +61,795 New
HSBC Holdings
60
HSBC Holdings
United Kingdom
$276K +$206K +60,000 New
BNP Paribas Financial Markets
61
BNP Paribas Financial Markets
France
$232K +$173K +50,463 New
Northwestern Mutual Wealth Management
62
Northwestern Mutual Wealth Management
Wisconsin
$230K +$172K +50,000 New
FM
63
Forward Management
California
$229K +$234K +68,000 New
Goldman Sachs
64
Goldman Sachs
New York
$224K +$167K +48,676 New
MWNA
65
Marshall Wace North America
New York
$211K +$158K +45,824 New
PPA
66
Parametric Portfolio Associates
Washington
$203K +$151K +44,050 New
UBS AM
67
UBS AM
Illinois
$197K +$147K +42,894 New
Principal Financial Group
68
Principal Financial Group
Iowa
$196K +$146K +42,559 New
BP
69
Ballentine Partners
Massachusetts
$138K +$103K +30,000 New
Bank of America
70
Bank of America
North Carolina
$124K +$92.4K +26,870 New
Wells Fargo
71
Wells Fargo
California
$120K +$89.2K +25,951 New
LWM
72
Lyons Wealth Management
Florida
$116K +$87.1K +25,340 New
OTF
73
Opus Trading Fund
New York
$110K +$82.1K +23,888 New
QIM
74
Quantitative Investment Management
Virginia
$90K +$67.4K +19,600 New
BMM
75
Berkshire Money Management
Massachusetts
$88K +$65.8K +19,150 New

AVNR Hedge Fund Activity: Q2 2013 in Review

95 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q2 2013, worth a combined $473M.

Buyers outnumbered sellers: 95 funds opened new AVNR positions and 0 closed out — a net gain of 95 holders — while 0 added to existing stakes and 0 trimmed.

  • 95 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $473M of AVANIR PHARMACEUTICALS, INC CL A stock for Q2 2013.
  • 95 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q2 2013 and 0 closed out, a net change of +95 holders.

Based on aggregated 13F filings for Q2 2013.